1410975-92-6

Upstream product

• 20780-74-9 7-bromoisatin 
• 20776-51-6 2-amino-3-bromo benzoic acid 
• 1410975-90-4 (7aS,9R)-9-(tert-butyldimethylsiloxy)-2-methylthio-6,7,7a,8,9,10-hexahydro-5H-pyrimido[5,4-f]pyrrolo[1,2-a][1,4]diazepin-5-one 
• 1341038-12-7 8-bromo-3-methyl-3H-quinazolin-4-one 
• 62-23-7 4-nitro-benzoic acid 
• 5909-24-0 4-chloro-2-methanesulfanylpyrimidine-5-carboxylic acid ethyl ester 
• 1410975-83-5 N-(((2S,4R)-4-hydroxypyrrolidin-2-yl)methyl)-2-nitrobenzenesulfonamide 
• 1410975-85-7 ethyl 4-((2S,4R)-4-hydroxy-2-((2-nitrophenylsulfonamido)methyl)pyrrolidin-1-yl)-2-(methylthio)pyrimidine-5-carboxylate 
• 1410975-89-1 ethyl 4-((2S,4R)-4-(tert-butyldimethylsilyloxy)-2-((2-nitrophenylsulfonamido)methyl)pyrrolidin-1-yl)-2-(methylthio)pyrimidine-5-carboxylate 

Relevant academic research and scientific papers

PYRIMIDO-DIAZEPINONE COMPOUND

Provided are a compound represented by general formula (I), or the pharmaceutically acceptable salt thereof, (wherein Ra represents a hydrogen atom or the like, R1 and R2 may be the same or different, and each represents a hydrogen atom, optionally substituted lower alkyl or cycloalkyl, or R1 and R2 are combined together with the adjacent nitrogen atom thereto to form nitrogen-containing heterocyclic group, and Z represents a bicyclic heterocyclic group in which optionally substituted two six-membered rings are fused to each other, or the like) and the like.